Brief: Panbela Therapeutics Inc - Co Has Requested Hearing And Intends To Promptly Provide Its Plan To Regain Compliance With The Minimum Bid Price Rule
06/01/2023 21:29
Jan 6 (Reuters) - Panbela Therapeutics Inc PBLA.O :
* PANBELA THERAPEUTICS INC - CO HAS REQUESTED HEARING AND
INTENDS
TO PROMPTLY PROVIDE ITS PLAN TO REGAIN COMPLIANCE WITH THE
MINIMUM BID PRICE RULE
* PANBELA THERAPEUTICS- INTENDS TO TAKE MEASURES TO REGAIN
COMPLIANCE, INCLUDING EFFECTING 1-FOR-40 REVERSE SPLIT AS
PREVIOUSLY APPROVED BY STOCKHOLDERS
Further company coverage: PBLA.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Panbela Therapeutics
See all newsBrief: Panbela Therapeutics Announces Third Independent Safety Review Of Phase 3 Aspire Clinical Trial DSMB Recommended Continuation With No Trial Modification
Brief: Nasdaq Notifies Panbela Therapeutics Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard
Brief: Panbela Announces Pricing of Approximately $9 Mln Public Offering
U.S. STOCKS ON THE MOVE-Fisker, Best Buy, NuStar Energy
Brief: Panbela Therapeutics Announces Exercise Of Warrants And Issuance Of New Warrants